We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Cabotegravir sodium and cabotegravir/rilpivirine
Australian Public Assessment Report
Device/Product Name
Vocabria and Cabenuva
Active ingredients
Cabotegravir sodium and cabotegravir/rilpivirine
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-04281-1-2 and PM-2019-04280-1-2
Submission Type
New chemical entity and New fixed dose combination
Decision
Both approved